CR MEDICAL (01515) announced its interim results for the six months ended June 30, 2025, reporting revenue of RMB 4.525 billion, representing a year-on-year decrease of 9.07%. Shareholder attributable profit reached RMB 340 million, declining 21.76% compared to the same period last year. Basic earnings per share stood at RMB 0.27, with the company proposing an interim dividend of 5 cents per share.

According to the announcement, during the reporting period, the hospital business segment generated revenue of RMB 4.259 billion, down 7.4% year-on-year. Outpatient and emergency visits increased by 1.0%, while inpatient admissions decreased by 3.9%. Due to reduced medical insurance reimbursement rates, average revenue per outpatient visit and per inpatient stay both declined by 5.8%.

As of June 30, 2025, the group operates and manages 103 medical institutions across 10 provinces and cities in China. During the reporting period, the group's hospitals handled approximately 5.1 million outpatient and emergency visits and 270,000 inpatient admissions, representing increases of 1.0% and decreases of 3.9% respectively compared to the same period last year.